Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
OPERATING ACTIVITIES    
Net loss and comprehensive loss $ (30,474) $ (24,289)
Items not involving current cash flows:    
Depreciation and amortization 563 403
Interest expense on lease liabilities 78 53
Share-based compensation expense 2,134 3,620
Gain on change in fair value of warrants (4,891) (3,604)
Accrued interest on Note payable 115
Warrant liability-foreign exchange adjustment 44
Changes in non-cash working capital balances    
Receivables 8,280
Prepaid expenses and deposits 709 (223)
Accounts payable and accrued liabilities 2,719 (441)
Deferred revenues 1,206  
Cash used in operating activities (19,676) (24,322)
FINANCING ACTIVITIES    
Exercise of Derivative warrants 2 8,000
January 2021 Equity Offering, net of issuance costs 10,375
February 2021 Equity Offering, net of issuance costs 21,093
Exercise of Equity warrants 1,985
Exercise of stock options 14
Proceeds from issuance of common shares 2,709
Note payable 135
Repayment of lease liabilities (308) (180)
Cash (used in) provided by financing activities (306) 44,131
INVESTING ACTIVITIES    
Purchase of property, plant and equipment (474) (333)
Purchase of patents (214) (268)
Cash used in investing activities (688) (601)
(Decrease) increase in cash and cash equivalents (20,670) 19,208
Cash and cash equivalents, beginning of the period 32,306 25,469
Cash and cash equivalents, end of the period $ 11,636 $ 44,677